Claritev Total Current Liabilities 2019-2025 | CTEV
Claritev total current liabilities from 2019 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Claritev Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $214 |
| 2023 | $167 |
| 2022 | $176 |
| 2021 | $142 |
| 2020 | $112 |
| 2019 | $86 |
| 2018 | $0 |
| Claritev Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $180 |
| 2024-12-31 | $214 |
| 2024-09-30 | $201 |
| 2024-06-30 | $181 |
| 2024-03-31 | $194 |
| 2023-12-31 | $167 |
| 2023-09-30 | $172 |
| 2023-06-30 | $147 |
| 2023-03-31 | $156 |
| 2022-12-31 | $176 |
| 2022-09-30 | $230 |
| 2022-06-30 | $148 |
| 2022-03-31 | $202 |
| 2021-12-31 | $142 |
| 2021-09-30 | $167 |
| 2021-06-30 | $112 |
| 2021-03-31 | $216 |
| 2020-12-31 | $112 |
| 2020-09-30 | $9 |
| 2020-06-30 | $2 |
| 2020-03-31 | $0 |
| 2019-12-31 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.632B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.506B | 58.15 |
| Hims & Hers Health (HIMS) | United States | $12.660B | 131.54 |
| Tempus AI (TEM) | United States | $9.553B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.486B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.076B | 63.69 |
| Hinge Health (HNGE) | United States | $3.030B | 0.00 |
| Privia Health (PRVA) | United States | $2.775B | 189.67 |
| Enovis (ENOV) | United States | $1.788B | 9.97 |
| Clover Health Investments (CLOV) | United States | $1.598B | 0.00 |
| Schrodinger (SDGR) | United States | $1.586B | 0.00 |
| Phreesia (PHR) | United States | $1.457B | 0.00 |
| Omnicell (OMCL) | United States | $1.423B | 25.10 |
| Azenta (AZTA) | United States | $1.223B | 56.85 |
| 10x Genomics (TXG) | United States | $1.173B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.593B | 0.00 |
| Talkspace (TALK) | United States | $0.534B | 159.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.384B | 0.00 |
| TruBridge (TBRG) | United States | $0.360B | 797.67 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.085B | 3.26 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |